{"schema_version":"secwatch.filing_event.v1","accession":"0001065949-22-000066","form_type":"8-K","ticker":"LIMX","cik":"0001803977","company_name":"Limitless X Holdings Inc.","filed_at":"2022-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.386344+00:00","generated_at":"2026-06-25T16:58:22.565475+00:00","sec_items":["1.01","3.02","5.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Bio Lab Naturals to acquire Limitless X in reverse merger; LXI shareholders to own ~90% of combined entity","bullets":["Bio Lab Naturals will acquire all of Limitless X (health/wellness, beauty, CBD) via share exchange.","LXI shareholders receive 97M BLAB common shares (plus 9M shares in 6 months), owning ~90% of combined company.","LXI CEO to purchase 500K shares of BLAB Series A Preferred Stock with super voting rights (60% votes), effecting change in control.","Closing targeted for May 20, 2022; transaction subject to customary conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0001065949-22-000066","json":"https://secwatch.observer/filing/0001065949-22-000066.json","markdown":"https://secwatch.observer/filing/0001065949-22-000066.md","text":"https://secwatch.observer/filing/0001065949-22-000066.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1803977/000106594922000066/0001065949-22-000066-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1803977/000106594922000066/blab8kmay132022.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T16:58:22.565475+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}